Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians
Authors:
Open Access
- 22 August 2019
- journal article
- research article
- Published by Springer Nature in Diabetes Therapy
- Vol. 10 (5) , 1553-1564
Abstract
Advances in continuous glucose monitoring and insulin pumps have allowed people with type 1 diabetes (T1D) and caregivers to accurately and continuously measure their glucose levels and make adjustments to insulin infusion. In recent years, algorithms for subcutaneous insulin dosing have been developed that can respond to changes in glucose in an automated fashion and “close the loop”. At present, a first-generation ‘hybrid closed-loop’, ‘artificial pancreas’ or ‘automated insulin dosing’ system, Medtronic 670G, is available commercially. Further systems are in clinical trials. Frustrated by the slow pace of innovation, people affected by diabetes have united online under the hashtag ‘#WeAreNotWaiting,’ to disseminate open-source diabetes technologies. One dimension of #WeAreNotWaiting is “looping” with a do-it-yourself artificial pancreas. Here we provide the perspectives of two adults with T1D, the parent of a child with T1D and three physicians who detail their experience with these systems. These personal and clinical perspectives highlight very clear metabolic and psychological benefits of these systems in real-world settings.Keywords
This publication has 10 references indexed in Scilit:
- Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of LifeJournal of Diabetes Science and Technology, 2018
- Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?Journal of Diabetes Science and Technology, 2018
- Closing the Loop with OpenAPS in People with Type 1 Diabetes—Experience from ItalyDiabetes, 2018
- Open Artificial Pancreas System Reduced Hypoglycemia and Improved Glycemic Control in Patients with Type 1 DiabetesDiabetes, 2018
- Improvements in A1C and Time-in-Range in DIY Closed-Loop (OpenAPS) UsersDiabetes, 2018
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysisBMJ, 2018
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 DiabetesJAMA, 2016
- Real-World Use of Open Source Artificial Pancreas SystemsJournal of Diabetes Science and Technology, 2016
- Pathway to Artificial Pancreas Systems Revisited: Moving DownstreamDiabetes Care, 2015
- Closed-loop insulin delivery: from bench to clinical practiceNature Reviews Endocrinology, 2011